NEUROPACE INC's ticker is NPCE and the CUSIP is 641288105. A total of 25 filers reported holding NEUROPACE INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $216,016 | +198.7% | 22,201 | +37.8% | 0.00% | – |
Q2 2023 | $72,316 | -3.6% | 16,106 | -0.4% | 0.00% | – |
Q1 2023 | $75,033 | +211.4% | 16,171 | 0.0% | 0.00% | – |
Q4 2022 | $24,095 | -60.5% | 16,171 | 0.0% | 0.00% | – |
Q3 2022 | $61,000 | +8.9% | 16,171 | +43.4% | 0.00% | – |
Q2 2022 | $56,000 | -88.7% | 11,275 | -81.3% | 0.00% | – |
Q1 2022 | $494,000 | -24.0% | 60,184 | -6.7% | 0.00% | – |
Q4 2021 | $650,000 | -37.3% | 64,527 | -1.3% | 0.00% | – |
Q3 2021 | $1,036,000 | -38.9% | 65,379 | -8.3% | 0.00% | – |
Q2 2021 | $1,696,000 | – | 71,277 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KCK LTD. | 5,621,111 | $56,661,000 | 40.01% |
Revelation Capital Management, LLC | 666,540 | $6,719,000 | 6.48% |
Soleus Capital Management, L.P. | 2,309,003 | $23,275,000 | 2.33% |
Orbimed Advisors | 4,012,281 | $40,444,000 | 0.52% |
Nantahala Capital Management | 305,906 | $3,084,000 | 0.11% |
KORNITZER CAPITAL MANAGEMENT INC /KS | 435,719 | $4,392,000 | 0.07% |
Bellevue Group AG | 507,930 | $5,120,000 | 0.05% |
LORD, ABBETT & CO. LLC | 355,972 | $3,588,000 | 0.01% |
PICTET ASSET MANAGEMENT SA | 560,444 | $5,649,000 | 0.01% |
Point72 Asset Management, L.P. | 136,200 | $1,373,000 | 0.01% |